-
Acura Pharmaceuticals, Inc. Announces the Passing of Andrew Reddick, President & CEO
Friday, April 29, 2011 - 4:16pm | 35Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) announced today with great sadness that Andrew D. Reddick, its President and Chief Executive Officer and a Director, passed away on April 28, 2011.
-
Abbott Receives U.S. FDA Approval for AndroGel 1.62% to Treat Men with Low Testosterone
Friday, April 29, 2011 - 3:00pm | 110Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration has approved AndroGel 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%. At the starting dose, the...
-
Married Put(z) 04-29-2011
Friday, April 29, 2011 - 2:51pm | 1059Cusick's Corner Equity markets continue to grind higher and the Big Caps are leading the way. Traders are watching the metals closely, more specifically Gold, GLD, and the strength in this trend is under some pressure. Now this does not mean that we won't get a headline that pops the metal, but...
-
Lilly In Advanced Talks To Resolve SEC Foreign Bribery Probe -DJ (LLY)
Friday, April 29, 2011 - 1:25pm | 24Lilly (NYSE: LLY) In Advanced Talks To Resolve SEC Foreign Bribery Probe, Reported By Dow Jones
-
Merck Up On Strong Earnings Today (MRK)
Friday, April 29, 2011 - 12:48pm | 258Merck & Co., Inc. (NYSE: MRK) reported strong earnings today, and shares are higher, as Wall Street rewards the earnings beat. Merck earned 34 cents per share, or 92 cents per share excluding items. This beat Wall Street estimates of 84 cents per share. Revenues also beat Wall Street...
-
Endo Pharmaceuticals Discloses DoJ Subpoena in Quarterly Filing (ENDP)
Friday, April 29, 2011 - 12:43pm | 18Endo Pharmaceuticals (NASDAQ: ENDP) discloses DoJ subpoena in quarterly filing.
-
New Treatment For Chronic Low Back Pain Approved by Health Canada (LLY)
Friday, April 29, 2011 - 12:14pm | 165Eli Lilly (NYSE: LLY) Canada announced today that Health Canada has approved Cymbalta(®) (duloxetine HCl) for the management of chronic low back pain (CLBP). The recommended dose is 60 mg once daily. The approval is based on the results of two randomized, double-blind, 12-13 week, placebo-...
-
Hearing Drug To Launch Next Week in Avanir Pharma (AVNR)
Friday, April 29, 2011 - 11:43am | 31Hearing Drug To Launch Next Week in Avanir Pharma (NASDAQ: AVNR) http://videos.thestreet.com/v/39927729/the-next-big-thing-in-biotech-dendreon-avanir.htm?CM_VEN=AD|TWR|JC
-
Dream Stocks: April's Strongest Performers (SIFY, AMRN, REDF, KUTV, ACAD)
Friday, April 29, 2011 - 11:06am | 318The following five stocks have made shareholders extremely happy recently, as they are the top percentage gainers in the market for the month of April. All of the companies reside in the NASDAQ, as pharmaceutical and internet stocks have garnered significant attention from investors and money...
-
Citi Reports Strong 1Q11 Results For Merck
Friday, April 29, 2011 - 11:03am | 213According to Citi, Merck (NYSE: MRK) reported strong 1Q11 results with EPS of $0.92 (+11%), +$0.07 above estimate and +$0.06 above the Street. Citi said that revenues came in $224M above projection at $11.58B (+1%) vs. 11.36B & the Street $11.37B (+$0.04 EPS impact). “The performance was...
-
Negative Rumors About Spectrum Pharmaceuticals Circulate (SPPI)
Friday, April 29, 2011 - 10:23am | 92Unconfirmed Negative rumors circulating at Spectrum Pharmaceuticals (Nasdaq: SPPI). Negative Posting http://www.thestreet.com/story/11099841/1/spectrum-pharma-fusilev-bubble-will-burst.html This article may include mentions of rumors, chatter, or unconfirmed information. Readers should beware...
-
Oppenheimer Comments On Endo Pharmaceuticals 1Q11 Results
Friday, April 29, 2011 - 9:59am | 140According to Oppenheimer, Endo Pharmaceuticals (NASDAQ: ENDP) reported adjusted EPS of $1.00, ahead of our $0.98 estimate and the Street estimate of $0.99. Oppenheimer said that we highlight that ENDP reported total revenues of $560M (higher than our $530M estimate) driven by higher generic...
-
Citi On ENDP 1Q11 EPS
Friday, April 29, 2011 - 9:34am | 97Citi has issued a report regarding the 1Q11 EPS for Endo Pharmaceuticals Holdings (NASDAQ: ENDP). According to the report, "We Maintained our ‘11E NEWCO (ENDP+AMS) EPS of $4.38 (+26%), Above the Street's $4.29 & ENDP's Reaffirmed $4.20(+21%)-$4.30(+24%) Range (see Fig. 1). We expect ENDP to...
-
Avanir Ticks Higher on TheStreet.com Video (AVNR)
Friday, April 29, 2011 - 9:10am | 70Avanir (NASDAQ: AVNR) is ticking over 2% higher this morning after TheStreet.com posted a video about the "next big thing in biotech." Adam Feuerstein, a TheStreet.com columnists, discusses the possible trading ideas for Avanir ahead of Dendreon (NASDAQ: DNDN) earnings release next week.
-
Friday Morning Market Summary 4/29/2011
Friday, April 29, 2011 - 9:00am | 355Merck & Co (NYSE: MRK) reported higher-than-expected first-quarter earnings, fueled by strong sales of its drugs for diabetes, asthma and rheumatoid arthritis. Merck & Co said it earned $1.04 billion, or 34 cents per share. That compared with $299 million, or 9 cents per share, a year...